Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#2 Victoria VR Victoria VR +11.93%
#3 Movement Movement +11.39%
#4 Palladium Network Palladium Network +9.28%
#5 DMT-NAT DMT-NAT +6.25%
#6 Cryptopia Cryptopia +4.73%
#7 Pons Pons +4.23%
#8 GRVT Token GRVT Token +3.85%
#9 MarsCoin MarsCoin +3.69%
#10 COTI COTI +3.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBI
Classificação em ações #42162
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical... China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment of health-related products. This range includes prescription and non-prescription drugs, refined and roughly processed traditional Chinese herbal medicines, family planning items, and various other pharmaceutical and healthcare products. The Pharmaceutical Manufacturing division, operating under the "Asio" brand, is responsible for producing and marketing a range of generic and clinical pharmaceuticals. This includes treatments for inflammation and bacterial infections, oncology drugs, cardiovascular medications, and hepatitis therapies. Key products manufactured by the company include Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was originally known as China Baicaotang Medicine Limited before adopting its current name, China BCT Pharmacy Group, Inc., in March 2010. Its corporate headquarters are situated in Liuzhou, People's Republic of China.
Preço da ação
$0.0001
Última sincronização: 2025-06-02
Valor de mercado
$3.82K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
CN
Negociar China BCT Pharmacy Group, Inc. (CNBI)

Categoria

Healthcare
Histórico de preços das ações de China BCT Pharmacy Group, Inc. (CNBI)
Preço de fecho mais alto: $0.00 em 2025-06-01

Preço de fecho mais baixo: $2.69 em 2010-03-01
Histórico de preços das ações da China BCT Pharmacy Group, Inc. de 2010 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2025 0.00%
2024 0.00%
2023 0.00%
2022 -12.00%
2021 -98.22%
2020 25.45%
2019 70.90%
2018 -5.20%
2017 -37.09%
2016 -33.40%
2015 -63.24%
2014 -78.85%
2013 -48.82%
2012 -88.75%
2011 -35.07%
2010 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $59.08 62.03%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $49.68 72.21%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $184.45 43.36%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 $62.39 4.91%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $113.04 55.27%
US